Preoperative chemotherapy for non-small cell lung cancer.

作者: A. Depierre , V. Westeel , P. Jacoulet

DOI: 10.1053/CTRV.2001.0218

关键词: Non small cellSurgeryInternal medicineRespiratory diseaseRandomized controlled trialOncologyMedicinePreoperative chemotherapyChemotherapyLung cancerStage (cooking)Radiation therapy

摘要: Surgery has been considered the standard of care in patients with early-stage non-small cell lung cancer (NSCLC), as well some cases stage III, for a long time. Poor survival after complete resection led to search new therapeutic strategies such combining anticancer treatments. However, at present time, attempts combine chemotherapy and radiotherapy surgery have failed show any significant impact on among completely resected NSCLC.

参考文章(51)
David J. Sugarbaker, James Herndon, Leslie J. Kohman, Mark J. Krasna, Mark R. Green, Results of cancer and leukemia group B protocol 8935 ☆ ☆☆ ★ ★★ ♢ ♢♢ ♦: A multiinstitutional phase II trimodality trial for stage IIIa (N2) non-small-cell lung cancer The Journal of Thoracic and Cardiovascular Surgery. ,vol. 109, pp. 473- 485 ,(1995) , 10.1016/S0022-5223(95)70278-4
K S Albain, V W Rusch, J J Crowley, T W Rice, A T Turrisi, J K Weick, V A Lonchyna, C A Presant, R J McKenna, D R Gandara, Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. Journal of Clinical Oncology. ,vol. 13, pp. 1880- 1892 ,(1995) , 10.1200/JCO.1995.13.8.1880
N C Choi, R W Carey, W Daly, D Mathisen, J Wain, C Wright, T Lynch, M Grossbard, H Grillo, Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer Journal of Clinical Oncology. ,vol. 15, pp. 712- 722 ,(1997) , 10.1200/JCO.1997.15.2.712
W Eberhardt, H Wilke, G Stamatis, M Stuschke, A Harstrick, H Menker, B Krause, M R Müeller, M Stahl, M Flasshove, V Budach, D Greschuchna, N Konietzko, H Sack, S Seeber, Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. Journal of Clinical Oncology. ,vol. 16, pp. 622- 634 ,(1998) , 10.1200/JCO.1998.16.2.622
A Niiranen, S Niitamo-Korhonen, M Kouri, A Assendelft, K Mattson, S Pyrhönen, Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study. Journal of Clinical Oncology. ,vol. 10, pp. 1927- 1932 ,(1992) , 10.1200/JCO.1992.10.12.1927
R L Burkes, R J Ginsberg, F A Shepherd, M E Blackstein, M E Goldberg, P F Waters, G A Patterson, T Todd, F G Pearson, J D Cooper, Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial. Journal of Clinical Oncology. ,vol. 10, pp. 580- 586 ,(1992) , 10.1200/JCO.1992.10.4.580
Jack A Roth, E.Neely Atkinson, Frank Fossella, Ritsuko Komaki, M.Bernadette Ryan, J.B Putnam, Jin Soo Lee, Hari Dhingra, Louis De Caro, Marvin Chasen, Waun Ki Hong, Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer Lung Cancer. ,vol. 21, pp. 1- 6 ,(1998) , 10.1016/S0169-5002(98)00046-4
Bertrand Dautzenberg, Jacques Benichou, Philippe Allard, Bernard Lebeau, Daniel Coetmeur, Jeanne-Marie Brechot, Marie J. Postal, Claude Chastang, Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non-small cell carcinoma results from a randomized phase II trial Cancer. ,vol. 65, pp. 2435- 2441 ,(1990) , 10.1002/1097-0142(19900601)65:11<2435::AID-CNCR2820651105>3.0.CO;2-2
Jean-Louis Pujol, Maurice Hayot, Philippe Rouanet, Thierry Le Chevalier, Franqois-Bernard Michel, Long-Term Results of Neoadjuvant Ifosfamide, Cisplatin, and Etoposide Combination in Locally Advanced Non-Small-Cell Lung Cancer Chest. ,vol. 106, pp. 1451- 1455 ,(1994) , 10.1378/CHEST.106.5.1451